Critical Care

official impact factor 4.60

Open Access Highly Access

Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy

Luigi Camporota, Eleonora Corno, Eleonora Menaldo, John Smith, Katie Lei, Richard Beale and Duncan Wyncoll*

Critical Care 2008, 12:R163 doi:10.1186/cc7163

Accesses  

  • Last 30 days: 41 accesses
  • Last year: 434 accesses
  • All time: 3070 accesses

Cited by

BioMed Central: 2 citations

Review   Free Highly Accessed

Year in review 2008: Critical Care - nephrology

Zaccaria Ricci, Claudio Ronco Critical Care 2009, 13:227 (21 October 2009)

Commentary   Free

Anticoagulant properties of drotrecogin alfa (activated) during hemofiltration in patients with severe sepsis

Anne CJM de Pont, Marcus J Schultz Critical Care 2009, 13:113 (2 February 2009)